par Keymeulen, Bart;Vandemeulebroucke, Evy;Ziegler, Anette Gabriele;Mathieu, Chantal;Kaufman, Leonard;Hale, Geoff;Gorus, Frans;Goldman, Michel 
;Walter, Markus;Candon, Sophie;Schandené, Liliane ;Crenier, Laurent ;De Block, Christophe;Seigneurin, Jean-Marie;De Pauw, Pieter;Pierard, Denis;Weets, Ilse;Rebello, Peppy;Bird, Pru;Berrie, Eleanor;Frewin, Mark;Waldmann, Herman;Bach, Jean-François;Pipeleers, Daniel;Chatenoud, Lucienne
Référence The New England journal of medicine, 352, 25, page (2598-2608)
Publication Publié, 2005-06
;Walter, Markus;Candon, Sophie;Schandené, Liliane ;Crenier, Laurent ;De Block, Christophe;Seigneurin, Jean-Marie;De Pauw, Pieter;Pierard, Denis;Weets, Ilse;Rebello, Peppy;Bird, Pru;Berrie, Eleanor;Frewin, Mark;Waldmann, Herman;Bach, Jean-François;Pipeleers, Daniel;Chatenoud, LucienneRéférence The New England journal of medicine, 352, 25, page (2598-2608)
Publication Publié, 2005-06
Article révisé par les pairs
| Titre: |
|
| Auteur: | Keymeulen, Bart; Vandemeulebroucke, Evy; Ziegler, Anette Gabriele; Mathieu, Chantal; Kaufman, Leonard; Hale, Geoff; Gorus, Frans; Goldman, Michel; Walter, Markus; Candon, Sophie; Schandené, Liliane; Crenier, Laurent; De Block, Christophe; Seigneurin, Jean-Marie; De Pauw, Pieter; Pierard, Denis; Weets, Ilse; Rebello, Peppy; Bird, Pru; Berrie, Eleanor; Frewin, Mark; Waldmann, Herman; Bach, Jean-François; Pipeleers, Daniel; Chatenoud, Lucienne |
| Informations sur la publication: | The New England journal of medicine, 352, 25, page (2598-2608) |
| Statut de publication: | Publié, 2005-06 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adolescent |
| Adult | |
| Antigens, CD3 -- immunology | |
| Autoantibodies -- blood | |
| Blood Glucose -- analysis | |
| C-Peptide -- biosynthesis | |
| Child | |
| Diabetes Mellitus, Type 1 -- blood | |
| Diabetes Mellitus, Type 1 -- drug therapy | |
| Diabetes Mellitus, Type 1 -- immunology | |
| Female | |
| Glucose Clamp Technique | |
| Herpesviridae -- isolation & purification | |
| Humans | |
| Hypoglycemic Agents -- therapeutic use | |
| Immunoglobulin G -- adverse effects | |
| Immunoglobulin G -- therapeutic use | |
| Insulin -- therapeutic use | |
| Islets of Langerhans -- drug effects | |
| Islets of Langerhans -- immunology | |
| Islets of Langerhans -- physiopathology | |
| Male | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase II | |
| Journal Article | |
| Multicenter Study | |
| Randomized Controlled Trial | |
| Research Support, Non-U.S. Gov't | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0028-4793 |
| info:doi/10.1056/NEJMoa043980 | |
| info:pii/352/25/2598 | |
| info:scp/20544443927 | |
| info:pmid/15972866 |
